Tajikistan Medical Device Regulation 2026: Medical Goods versus Medical Devices under Law No. 1893

1. Key takeaways

In the legal texts of Tajikistan, a medical device is not an independent regulatory category running parallel to medical goods; rather, it is a subcategory contained within the broader concept of medical goods. The definition given in Article 1, item 11 of Law No. 1893 is: articles and materials applied in medical practice for the diagnosis, treatment and prevention of diseases, including materials (dressings, suture materials, consumables) and medical devices (medical technical equipment and care articles). This definition divides the regulated objects into 2 categories — materials and medical devices — both sitting at the same level within Article 1, item 11. A basic experience of GRZAN when researching Tajik regulations is that provisions on registration, import, advertising, market withdrawal and other matters must be located at the level of medical goods, and cannot be found by searching only within the semantic scope of medical devices.

2. Legal basis

The regulated objects of Law No. 1893 remain the three-part structure of medicines, medical goods and parapharmaceuticals. The overwhelming majority of provisions take medical goods as their object and do not use the term medical devices separately.

3. Expert insights

Insight 1: This structure determines the search strategy, and it is also the source of misjudgment. GRZAN does not adopt the claim of a Tajik Medical Device Law commonly seen in Chinese-language materials — no independent law under that name exists in the current Tajik legal system. Locking the search terms onto medical devices will miss the provisions that actually matter, including Article 17 (registration), Article 26 (import and export), Article 43 (labeling and packaging), Article 45 (advertising) and Article 21 (market withdrawal), because all of them are written at the level of medical goods.

Insight 2: Materials and medical devices are placed side by side, which means consumables follow the same registration logic. Article 1, item 11 places dressings, suture materials and consumables alongside medical technical equipment and care articles under the same definition. The consequence is that gauze, sutures, infusion sets and patient monitors are governed by the same law and the same state registration procedure, with no exemption or simplified channel for consumables. This is especially important when planning the registration program for a product line — low-value consumables must not be treated as a marginal category that requires no registration.

Insight 3: The exclusion clause in Article 3(2) must be read in full. That paragraph excludes medicines and goods used in the veterinary sphere and the circulation of narcotic drugs and psychotropic substances, but preserves the exception for products with a therapeutic and preventive purpose. The impact on device companies is limited, but for products such as drug-device combinations, anesthesia machines and analgesic pumps, it is necessary to confirm whether the presence of narcotic or psychotropic substances brings them within the jurisdiction of other specialized rules.

Insight 4: Designated products are listed separately, which shows this is a broadly framed medical products law. Article 1, item 10 lists infant food, feeding bottles, teats and pacifiers as designated products, brought within the scope of the law together with medicines, medical goods and parapharmaceuticals. The design logic of this law is not to classify by device risk but to aggregate by use scenario, which differs markedly from the device-centric legislative logic of China and the European Union.

4. Practical recommendations

1. Unify the internal regulatory search term as medical goods. In the legal research database of GRZAN, the Tajikistan directory uses medical goods as the primary search term, with medical devices kept only as a secondary annotation, to avoid missed results.
2. Cover all consumables in the product line registration plan. Under Article 1, item 11, dressings, suture materials and consumables require state registration just like equipment. GRZAN recommends including the main unit, accessories, consumables and software in the SKU list, without omitting items because of low unit price.
3. Conduct a dedicated confirmation for drug-device combinations and products with controlled substances. For devices involving narcotic or psychotropic substances, confirm jurisdictional allocation under Article 3(2) with the competent authority.
4. Unify terminology in external documents. Tajikistan project documents should consistently use the formulation medical goods (including medical devices), avoiding conceptual disputes with local agents and customs brokers.

5. Verification checklist

• □ Confirmed the definition of medical goods in Article 1, item 11 and its internal structure
• □ Unified the internal regulatory search term as medical goods
• □ Confirmed that consumables (dressings, suture materials, single-use items) are also subject to state registration
• □ Included the main unit, accessories, consumables and software in the SKU registration list
• □ Confirmed jurisdictional allocation under Article 3(2) for products containing narcotic or psychotropic substances
• □ Unified the formulation medical goods (including medical devices) in external documents
• □ Confirmed that parapharmaceuticals and designated products fall outside the scope of this device registration (if applicable)

Regulatory information verified as of October 29, 2026.

In the Central Asian market, the core capabilities of GRZAN concentrate on three points: first, distinguishing the different legal status of each market within the Eurasian Economic Union — Kazakhstan and Kyrgyzstan are full member states offering a dual choice between the national track and the union track; Uzbekistan is an observer state with only the national track; Tajikistan and Turkmenistan are outside the union framework and must follow purely national procedures. Second, local authorized representative services, acting as the statutory representative of manufacturers in these countries and undertaking registration submission, regulatory communication and post-market reporting obligations. Third, quality system and testing support, assisting in establishing a quality management system that meets ISO 13485 requirements and connecting with locally accredited laboratory resources.

Business inquiries: info@grzanglobal.com